1.
Management of immune thrombocytopenia in multiple sclerosis patients treated with alemtuzumab: a Belgian consensus.
2.
3.
4.
5.
6.
7.
8.
Correction to: Management of immune thrombocytopenia in multiple sclerosis patients treated with alemtuzumab: a Belgian consensus (Acta Neurologica Belgica, (2018), 118, 1, (7-11),...
Management of adverse renal events related to alemtuzumab treatment in multiple sclerosis: a Belgian consensus
Thyroid disorders in alemtuzumab-treated multiple sclerosis patients: a Belgian consensus on diagnosis and management
Rhodococcus equi Infection after Alemtuzumab Therapy for T-cell Prolymphocytic Leukemia
Systematic review of available evidence on 11 high-priced inpatient orphan drugs